Composition : Vilanterol 25mcg + Fluticasone Furoate 100mcg rota cap
Dosage Form : Rota cap
Packaging Type : Bottle
Packaging : 30 Capsules
Price : ₹0/-
Please Contact For Best Price
Flutialfa VF is a combination inhalation therapy designed to provide effective management of asthma and chronic obstructive pulmonary disease (COPD). Each Rota Cap contains Vilanterol (25 mcg), a long-acting beta-agonist (LABA), and Fluticasone Furoate (100 mcg), a potent inhaled corticosteroid (ICS). This dual-action formulation works synergistically to improve lung function, reduce inflammation, and alleviate respiratory symptoms.
Vilanterol acts by stimulating beta-2 adrenergic receptors in the airway smooth muscle, leading to bronchodilation and improved airflow. This helps to relieve symptoms such as wheezing and shortness of breath. Fluticasone Furoate, on the other hand, reduces airway inflammation and hyperreactivity, addressing the underlying causes of asthma and COPD. Together, these components provide comprehensive control of respiratory conditions, allowing patients to breathe more easily and engage in daily activities with greater comfort.
Read More